NDC 80425-0314-01 - Minocycline hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0314
- Requested NDC
- 80425-0314-01
- Package NDCs from labels
- 80425-0314-1, 80425-0314-2, 80425-0314-3, 80425-0314-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Minocycline hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0314-1 | Minocycline hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 80425-0314-2 | Minocycline hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 80425-0314-3 | Minocycline hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0314 | MINOCYCLINE HYDROCHLORIDE CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f901a1ba-1716-8795-e053-6294a90a4e77.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0314-1 | EA - Each | 80425-0314 | 653d204f-3fba-4924-b79e-2cd154f86e4c | 1 | 2023-06-06 |
| 80425-0314-2 | EA - Each | 80425-0314 | bf184420-b29b-4035-bf5b-6dbf31599700 | 1 | 2023-06-06 |
| 80425-0314-3 | EA - Each | 80425-0314 | 14b81cd7-f3d4-4a6a-9de3-430059c885a5 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3e74e8a3-2670-97f5-e063-6394a90a361e | 2026-08-03 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3e796794-b731-61d6-e063-6394a90aa9b3 | 2026-07-31 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Major Pharamceuticals | fd86ff45-37d0-4501-b9fb-e1836e4a8be4 | 2026-07-16 | Warnings, Adverse reactions | ANDA065062 197984 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | caa99901-467c-4e99-b7e9-fbabdf5d118c | 2026-07-08 | Warnings, Adverse reactions | 197984 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | REMEDYREPACK INC. | 0becbde8-6ec5-4830-a0d9-cfdb7b15eb84 | 2026-07-03 | Warnings, Adverse reactions | 197984 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 093ff3c7-3ecc-47b4-9ae6-5218bcd262b2 | 2026-06-26 | Warnings, Adverse reactions | ANDA065062 197985 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 65767ae3-b1ed-4492-90f2-703b2c7e0f38 | 2026-06-24 | Warnings, Adverse reactions | ANDA065062 197984 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 87a137c6-dd53-44d3-ab49-ef78ebed35c8 | 2026-06-12 | Warnings, Adverse reactions | 197984 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1ec20539-0421-4eac-95ed-e9acc6329fd0 | 2026-06-12 | Warnings, Adverse reactions | 197985 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 7e2390b7-242c-43ff-afb3-b0a5e79351d3 | 2026-05-13 | Warnings, Adverse reactions | ANDA065062 197984 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | c11bfea8-6079-44ce-b8e1-20bfba631bec | 2026-05-04 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 6e0efd1a-5a09-4030-8fe2-f98334cdeb0e | 2026-04-22 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 9c43389b-dc98-41f3-80bf-73d916ad6843 | 2026-04-22 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | A-S Medication Solutions | c7d0226e-5ac5-4fb1-9849-9d6663a2e8ad | 2026-04-17 | Warnings, Adverse reactions | ANDA065062 197984 197985 0020414E5U |
| MINOCYCLINE HYDROCHLORIDE | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | bae17358-1180-4ca8-b163-f9a6f4f83a3d | 2026-04-09 | Warnings, Adverse reactions | 0020414E5U |
| MINOCYCLINE HYDROCHLORIDE | MINOCYCLINE HYDROCHLORIDE | Torrent Pharmaceuticals Limited | 3539f84e-b489-4914-96c1-ac3731032971 | 2026-04-08 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Torrent Pharmaceuticals Limited | 55df55fb-18ec-4e00-9ed0-10bba0da513b | 2026-04-02 | Warnings, Adverse reactions | ANDA065062 13668-484 197984 314108 197985 4ee4f6d7-55da-406d-9a32-de923b01c15c 55df55fb-18ec-4e00-9ed0-10bba0da513b 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | 409dddb0-be3a-4ae3-ab39-88a6cd50a219 | 2026-03-25 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | b3236a5c-8a5d-4d5d-9656-aee72a4c482b | 2026-03-25 | Warnings, Adverse reactions | 0020414E5U |
| Minocycline Hydrochloride | MINOCYCLINE HYDROCHLORIDE | Bryant Ranch Prepack | a16012ce-5754-4177-bfb7-dcce696a7189 | 2026-03-25 | Warnings, Adverse reactions | 0020414E5U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.